HGPI convened a roundtable on “The Increasing Role of Japanese Pharmaceutical Companies in Global Health.” This meeting was held in accordance with online publication of “Access to Medicine Index 2018” by the Access to Medicine Foundation (published on November 20, 2018).


The roundtable was jointly hosted by the Access to Medicine Foundation, the Health and Global Policy Institute (HGPI), and the Japan International Cooperation Agency (JICA). Support was also provided by the Japanese Ministry of Foreign Affairs (MOFA).



■Seminar Overview
Date and Time：Tuesday, December 11, 2018  08:30 to 10:30
Venue ：Grand Cube 3F, Otemachi Financial City, Global Business Hub Tokyo
Program：
08:30-08:35 Opening Remarks
　Yasuhiro Suzuki（Chief Medical and Global Health Officer and Vice-Minister for Health, Ministry of Health, Labour and Welfare of Japan）
08:35-09:00 Access to Medicine Index 2018: Key Findings
　Danny Edwards（Research Program Manager, Access to Medicine Foundation）
09:00-09:30 Q&A
09:30-09:40 Discussants: Building on the results of the 2018 Access to Medicine Index
　Sumi Manabu（Director, Global Health Policy Division, International Cooperation Bureau, Ministry of Foreign Affairs of Japan）
　Ritsuko Yamagata（Director, Health Team 2, Human Development Department, Japan International Cooperation Agency）
09:40-10:25 Discussion
10:25-10:30 Closing Remarks
　Damiano de Felice（Director of Strategy, Access to Medicine Foundation）